A novel compound JPM8: in vivo penile activity promotion in rats, effect on the relaxation and cGMP/cAMP accumulation in isolated rabbit corpora cavernosa

被引:0
作者
T S El-Thaher
S Khatib
M Saleem
A Shnoudeh
A A Badwan
机构
[1] The Jordanian Pharmaceutical Manufacturing Ltd,Physiology Department
[2] Faculty of Medicine,Department of Pharmacy
[3] Jordan University of Science and Technology,undefined
[4] School of Health Sciences,undefined
[5] King′s College,undefined
[6] University of London,undefined
来源
International Journal of Impotence Research | 2002年 / 14卷
关键词
JPM8; phosphodiesterase type 5 (PDE 5); inhibitors; erectile dysfunction; sildenafil; cGMP;
D O I
暂无
中图分类号
学科分类号
摘要
JPM8 is a novel sildenafil-like PDE5 inhibitor. Its efficacy was tested in vivo by the oral administration of drugs to a rat model and recording penile activity changes. Effect on the relaxation of the rabbit cavernosa was tested in vitro using an organ bath were drugs are added to the tissue media and relaxation was recorded using a transducer connected to a chart recorder. The accumulation of cGMP and cAMP was measured by incubation of cavernosa strips and then extracting the produced cGMP and cAMP in the incubation mixture, then quantitating it using ELISA. JPM8 showed increased and promoted sexual and penile activity in rats in a similar but slightly higher trend than the positive control sildenafil. JPM8 was more efficient in relaxing the rabbit corpora cavernosa than sildenafil. The cGMP and cAMP accumulation showed a similar trend for both drugs. We concluded that JPM8 was very effective in promoting sexual activity in rats, relaxing the corpora cavernosa and promoting cGMP accumulation in rabbits.
引用
收藏
页码:453 / 461
页数:8
相关论文
共 57 条
[1]  
Wagner G(1998)Clinical review. Update on male erectile dysfunction Br Med J 316 678-682
[2]  
Saenz de Tejada I(1995)Role of nitric oxide in the physiology of erection Biol Reprod 52 485-489
[3]  
Burnett AL(1999)Comparative tolerability and efficacy of treatments of impotence Drug Safety 20 133-146
[4]  
Meinhardt W(1996)Sildenafil (Viagra Bioorg Med Chem Lett 6 1819-1824
[5]  
Kropman RF(1993)), a potent and selective inhibitor of type 5-cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction J Med Chem 36 3765-3770
[6]  
Vermeji P(2000)Cyclic GMP phosphodiesterease inhibitors. 1: The discovery of a novel inhibitor, 4-((3,4-(methylenedioxy)benzyl)amino)-6,7,8-trimethoxy-quinazoline Chem J Med 43 2523-2529
[7]  
Terrett NK(2001)4-(3-chloro-4-methoxybenzyl)aminophthalazines: synthesis and inhibitory activity towards phosphodiesterase 5 Bioorg Med Chem 9 1609-1616
[8]  
Bell AS(2001)Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues Int J Impot Res 13 135-139
[9]  
Brown D(1989)General use of animal models for the investigation of the physiology of erection J Urol 141 656-661
[10]  
Ellis P(1994)The rat as a model for the study of penile erection Eur Uro 25 62-70